RE: Government test6 Sep 2021 12:46
Sandy, schools are using Orient Gene for onsite testing and FlowFlex for at home testing.
The school guidance also suggested that Innova may be provided for home use, but I think that may just be until stocks are run down.
As with test and trace it looks like FlowFlex/Orient Gene, which are both nasal swab only with pre-filled buffer tubes are the DHSC tests of the moment.
I think this bodes well for Mologic/Visitect as our test follows the same process, so no complicated mixed messaging needed from DHSC if they change tests. Not to mention, of course, that Mologic/Visitect are UK developed, uk manufactured, and performs better.
As per the Investor Presentation, all UK diagnostics manufacturing, combined, would not be able to meet all the needs of the UK market, let alone the big wide world.
In addition to 9m school kids being asked to continue testing, twice a week, there is test and trace which DHSC are still pushing strongly
https://twitter.com/DHSCgovuk/status/1434818662691606528
https://twitter.com/DHSCgovuk/status/1434554418276536321
And in addition there are core NHS, care homes and approved Key industries too.
It really does stand, even after this time, that Omega are in a strong position to sell all they can make.
And the more that is understood of Covid, the longer it looks like it will be with us.
The longer it's with us, the more revenue we can earn, more opportunity to expand, and may even result in higher P/E ration too.
I think we're in for a tough Autumn/Winter, in the UK alone, even with a heavily vaccinated population. Look at Israel as an example.
> UK Schools back this week
> More people back to work (my work place is pushing the messaging of twice weekly testing)
> No enforced isolation for close contact cases
> Inclimate weather inbound
> New variants emerging
> Spikes and Waves continuing to be cyclic globally
> Vaccines becoming less trusted/effective
I personally think delay in news on the DHSC front is due to Mologic/Visitect being lined up as the selected test, meaning no TT needed, just fire up the £17m loan kit and off we go.
Let's not forget, too, that there is a whole wide world out there needing tests, with Omega putting a lot of emphasis on the US market at the moment.
I won't deny it's been a tough hold, at times, but every time I look at the fundamentals and the roadmap of what's to come it becomes a lot less tough.. and just a minor frustration that it doesn't happen sooner.
It's certainly a share to help one with Patience issues.
To all genuine LTH.. good luck.
Sign In
Follow the stocks
